Page 5 - hypertension_newsletter4_Final
P. 5

REFLECTIONS
                                                                                                                   Hypertension
     Hypertension Global Newsletter #4 2023


     prescribed medications was also similar in the two groups.  among older men an invitation to undergo comprehensive CV
                                                                screening did not significantly reduce the incidence of death of
                                                                                                                   Hypertension
     By design, the trial assessed the effect of being invited to   any course at more than five years, a longer-term follow-up may
     undergo screening rather than the effects of actual screening.   be needed.
     However, only 62% of invited men underwent screening;
     therefore, the results may underestimate the effects of actual
     screening. The men who agreed to screening may be those who
     are already interested in maintaining health (healthy user bias)
     and therefore may not be representative of the entire population.
     The challenge may be in convincing those at highest risk (due
     to unidentified/ untreated hypertension, dyslipidaemia, diabetes,
     etc.) to undergo screening.

     Results of subgroup analyses suggest the possibility of a
     greater benefit of screening among participants in the younger
     age group (65 to 69 years of age). However, this subgroup was
     one of the multiple subgroups assessed, without adjustment for       WATCH A QUICK TAKE VIDEO SUMMARY
     multiplicity, and further study is needed to confirm the results. It   OF THE ARTICLE HERE (1 MIN 46 SEC).
     remains unclear whether these results would apply to women,
     other age groups, non-white persons, or persons living in
     countries with different health-care systems.
                                                                         CLICK HERE
     The current follow-up was a median of 5.6 years, but the trial      FOR THE LINK TO FULL ARTICLE
     was powered based on a planned 10 years of follow-up. While


     PATHOPHYSIOLOGY


     Arterial stiffness precedes hypertension and metabolic risks in youth: A review.
     Agbaje AO. J Hypertens. 2022 Oct 1;40(10):1887-1896.

     Arterial stiffness is a strong predictor of CV events and
     mortality in middle-aged and older adults. Preventing or
     decreasing arterial stiffness in adolescence may provide
     cardiometabolic health benefits later in life. This review article
     summarizes recent epidemiological evidence in the adolescent
     population supporting the value of arterial stiffness as a novel
     risk factor for hypertension, overweight/obesity, and insulin
     resistance. It also offers suggestions for incorporating arterial
     stiffness measures into routine paediatric and young adult
     clinical practice.

     Arterial stiffness increases with age across the life course and
     excessive stiffening could lead to early organ dysfunction and
     damage. Higher arterial stiffness in early life may result from
     maternal smoking habits, early life smoking patterns, high salt
     intake, genetic programming, obesity, elevated blood pressure,
     and other poor cardiometabolic and lifestyle factors.








          TABLE OF CONTENTS
   1   2   3   4   5   6   7   8   9   10